Quantitative analysis of the effects of brushing, flossing, and mouthrinsing on supragingival and subgingival plaque microbiota: 12-week clinical trial
Background Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic action...
Saved in:
| Published in | BMC oral health Vol. 24; no. 1; pp. 575 - 17 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
17.05.2024
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1472-6831 1472-6831 |
| DOI | 10.1186/s12903-024-04362-y |
Cover
| Abstract | Background
Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin.
Methods
Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing.
Results
286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only.
Conclusions
This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen.
Trial registration
The trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. |
|---|---|
| AbstractList | Background
Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin.
Methods
Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing.
Results
286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only.
Conclusions
This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen.
Trial registration
The trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. Background Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin. Methods Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine[R] Cool Mint[R] Antiseptic (BA); brushing and rinsing with Listerine[R] Cool Mint[R] Zero (BZ); or brushing, flossing, and rinsing with Listerine[R] Cool Mint[R] Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing. Results 286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only. Conclusions This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen. Trial registration The trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. Keywords: Oral microbiome, Mouthrinse, Listerine, Propidium monoazide, Dental plaque Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin. Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing. 286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only. This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen. The trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. BackgroundTranslational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin.MethodsSubjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing.Results286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only.ConclusionsThis publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen.Trial registrationThe trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin. Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine[R] Cool Mint[R] Antiseptic (BA); brushing and rinsing with Listerine[R] Cool Mint[R] Zero (BZ); or brushing, flossing, and rinsing with Listerine[R] Cool Mint[R] Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing. 286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only. This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen. Abstract Background Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin. Methods Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing. Results 286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only. Conclusions This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen. Trial registration The trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin.BACKGROUNDTranslational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel method for quantitative analysis was applied in this 12-week clinical trial to understand the mechanical vs. chemotherapeutic actions of brushing, flossing, and mouthrinsing against the supragingival dental plaque microbiome. Enumeration of viable bacteria using vPCR was also applied on supragingival plaque for validation and on subgingival plaque to evaluate interventional effects below the gingival margin.Subjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing.METHODSSubjects with gingivitis were enrolled in a single center, examiner-blind, virtually supervised, parallel group controlled clinical trial. Subjects with gingivitis were randomized into brushing only (B); brushing and flossing (BF); brushing and rinsing with Listerine® Cool Mint® Antiseptic (BA); brushing and rinsing with Listerine® Cool Mint® Zero (BZ); or brushing, flossing, and rinsing with Listerine® Cool Mint® Zero (BFZ). All subjects brushed twice daily for 1 min with a sodium monofluorophosphate toothpaste and a soft-bristled toothbrush. Subjects who flossed used unflavored waxed dental floss once daily. Subjects assigned to mouthrinses rinsed twice daily. Plaque specimens were collected at the baseline visit and after 4 and 12 weeks of intervention. Bacterial cell number quantification was achieved by adding reference amounts of DNA controls to plaque samples prior to DNA extraction, followed by shallow shotgun metagenome sequencing.286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only.RESULTS286 subjects completed the trial. The metagenomic data for supragingival plaque showed significant reductions in Shannon-Weaver diversity, species richness, and total and categorical bacterial abundances (commensal, gingivitis, and malodor) after 4 and 12 weeks for the BA, BZ, and BFZ groups compared to the B group, while no significant differences were observed between the B and BF groups. Supragingival plaque vPCR further validated these results, and subgingival plaque vPCR demonstrated significant efficacy for the BFZ intervention only.This publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen.CONCLUSIONSThis publication reports on a successful application of a quantitative method of microbiome analysis in a clinical trial demonstrating the sustained and superior efficacy of essential oil mouthrinses at controlling dental plaque compared to mechanical methods. The quantitative microbiological data in this trial also reinforce the safety and mechanism of action of EO mouthrinses against plaque microbial ecology and highlights the importance of elevating EO mouthrinsing as an integral part of an oral hygiene regimen.The trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231.TRIAL REGISTRATIONThe trial was registered on ClinicalTrials.gov on 31/10/2022. The registration number is NCT05600231. |
| ArticleNumber | 575 |
| Audience | Academic |
| Author | Bosma, Mary Lynn Min, Kyungrok McGuire, James A. Milleman, Jeffery DelSasso, Alicia Milleman, Kimberly R. John, Gabriella |
| Author_xml | – sequence: 1 givenname: Kyungrok surname: Min fullname: Min, Kyungrok email: kmin4@kenvue.com organization: Johnson & Johnson Consumer Inc – sequence: 2 givenname: Mary Lynn surname: Bosma fullname: Bosma, Mary Lynn organization: Johnson & Johnson Consumer Inc – sequence: 3 givenname: Gabriella surname: John fullname: John, Gabriella organization: Johnson & Johnson Consumer Inc – sequence: 4 givenname: James A. surname: McGuire fullname: McGuire, James A. organization: Johnson & Johnson Consumer Inc – sequence: 5 givenname: Alicia surname: DelSasso fullname: DelSasso, Alicia organization: Johnson & Johnson Consumer Inc – sequence: 6 givenname: Jeffery surname: Milleman fullname: Milleman, Jeffery organization: Salus Research, Inc – sequence: 7 givenname: Kimberly R. surname: Milleman fullname: Milleman, Kimberly R. organization: Salus Research, Inc |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38760758$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kttu1DAQhiNURA_wAlygSNxwQYpPcRxuUFVxqFQJIcG1NXHsrJesvdjOon0SXhfvpmy7CKFc2DP55rdm5j8vTpx3uiieY3SJseBvIiYtohUirEKMclJtHxVnmDWk4oLikwf30-I8xiVCuBGMPSlOqWg4ampxVvz6MoFLNkGyG12Cg3EbbSy9KdNCl9oYrdI-7MIUF9YNr0sz-hj3N3B9ufJTWgTrdpnSuzJO6wBDDuwGxj0Rp-4Qr0f4MelyZVXwnfUJ3paYVD-1_l6q0TqrMpOChfFp8djAGPWzu_Oi-Pbh_dfrT9Xt548311e3larrNlWKCmBdx2uC6oYSXnecUYJarjlhwvSE1IxxjU1vWqAtYbwGwZVh1AiVh0cviptZt_ewlOtgVxC20oOV-4QPg4SQrBq1FNR0FERPeoFYfgaIwjVuWgqqY4h1WevdrLWeupXulXYpwHgkevzH2YUc_EZijBEhGGWFV3cKwec5xSRXNio9juC0n6KkqOacE96yjL78C136KeT97SjORUsbRu-pAXIH1hmfH1Y7UXnVtCyPB3Ocqct_UPnrdd5UNp2xOX9U8OJhp4cW__gqA2QG8p5jDNocEIzkzrxyNq_M5pV788ptLqJzUcywG3S4b-k_Vb8B_Srx1g |
| Cites_doi | 10.1016/j.jdent.2010.03.012 10.14219/jada.archive.2003.0167 10.1186/1471-2180-9-259 10.1902/jop.1970.41.1.41 10.1177/0022034509346811 10.1111/j.1600-0765.1989.tb00860.x 10.14219/jada.archive.2004.0217 10.1111/j.1600-051X.1994.tb00736.x 10.1038/npjbiofilms.2016.18 10.1177/00220345600390021601 10.1128/JCM.43.11.5721-5732.2005 10.1902/jop.2006.050362 10.1186/s12903-017-0454-6 10.1902/jop.1994.65.1.30 10.1128/MMBR.66.3.486-505.2002 10.1371/journal.pone.0061217 10.1016/j.jmb.2019.05.016 10.1034/j.1600-051x.2000.027003157.x 10.1093/nar/gkaa1023 10.1146/annurev.mi.42.100188.003211 10.1016/j.adaj.2015.02.011 10.1111/j.1600-051X.1985.tb00937.x 10.1111/j.1600-051X.2007.01096.x 10.1038/nrmicro2381 10.1111/j.1399-302x.2004.00168.x 10.1902/jop.2007.070120 10.1038/ismej.2010.133 10.1111/idh.12307 10.1080/20002297.2019.1687397 10.1186/s12903-024-04365-9 10.1186/1745-6215-12-262 10.1128/JB.01631-09 10.1111/j.1600-051x.2005.00674.x 10.1186/s12903-024-03924-4 10.1111/j.1600-051X.1989.tb00003.x 10.1111/j.1600-051X.1998.tb02419.x 10.1128/jb.175.11.3247-3252.1993 10.1128/JB.00542-10 10.1111/j.1600-051X.1988.tb01020.x 10.1034/j.1600-051X.30.s5.4.x 10.1034/j.1600-051x.2000.027004256.x 10.1111/j.1600-051X.1994.tb00748.x |
| ContentType | Journal Article |
| Copyright | The Author(s) 2024 2024. The Author(s). COPYRIGHT 2024 BioMed Central Ltd. 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2024 – notice: 2024. The Author(s). – notice: COPYRIGHT 2024 BioMed Central Ltd. – notice: 2024. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12903-024-04362-y |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Database ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Dentistry |
| EISSN | 1472-6831 |
| EndPage | 17 |
| ExternalDocumentID | oai_doaj_org_article_83fb3a8d2d804643a2c151793acb404b PMC11102210 A794225161 38760758 10_1186_s12903_024_04362_y |
| Genre | Randomized Controlled Trial Journal Article |
| GeographicLocations | United States United States--US New Jersey |
| GeographicLocations_xml | – name: United States – name: New Jersey – name: United States--US |
| GrantInformation_xml | – fundername: Johnson & Johnson Consumer Inc, United States |
| GroupedDBID | --- 0R~ 23N 2WC 34H 53G 5GY 5VS 6J9 6PF 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACPRK ADBBV ADFRT ADRAZ ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK IAO IHR INH INR ITC IVC KQ8 LK8 M1P M48 M7P M~E O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ TR2 UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7QP 7XB 8FK AZQEC DWQXO GNUQQ K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c559t-c38a4bb6520573265b6432096e6248fd225446e1fdf9a392465a86cf43f8c9033 |
| IEDL.DBID | 7X7 |
| ISSN | 1472-6831 |
| IngestDate | Wed Aug 27 01:28:57 EDT 2025 Thu Aug 21 18:35:33 EDT 2025 Fri Sep 05 06:15:49 EDT 2025 Fri Jul 25 19:15:09 EDT 2025 Tue Jun 17 22:10:20 EDT 2025 Tue Jun 10 21:05:40 EDT 2025 Mon Jul 21 05:40:07 EDT 2025 Tue Jul 01 01:19:06 EDT 2025 Sat Sep 06 07:26:41 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Dental plaque Propidium monoazide Listerine Mouthrinse Oral microbiome |
| Language | English |
| License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c559t-c38a4bb6520573265b6432096e6248fd225446e1fdf9a392465a86cf43f8c9033 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.proquest.com/docview/3066893743?pq-origsite=%requestingapplication% |
| PMID | 38760758 |
| PQID | 3066893743 |
| PQPubID | 42535 |
| PageCount | 17 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_83fb3a8d2d804643a2c151793acb404b pubmedcentral_primary_oai_pubmedcentral_nih_gov_11102210 proquest_miscellaneous_3056662694 proquest_journals_3066893743 gale_infotracmisc_A794225161 gale_infotracacademiconefile_A794225161 pubmed_primary_38760758 crossref_primary_10_1186_s12903_024_04362_y springer_journals_10_1186_s12903_024_04362_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-05-17 |
| PublicationDateYYYYMMDD | 2024-05-17 |
| PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-17 day: 17 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC oral health |
| PublicationTitleAbbrev | BMC Oral Health |
| PublicationTitleAlternate | BMC Oral Health |
| PublicationYear | 2024 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | PE Kolenbrander (4362_CR40) 1988; 42 HV Worthington (4362_CR3) 2019; 4 AM Valm (4362_CR1) 2019; 431 GA Van der Weijden (4362_CR27) 1994; 21 SC Cortelli (4362_CR9) 2013; 26 DH Fine (4362_CR13) 2007; 78 S Periasamy (4362_CR52) 2010; 192 PE Kolenbrander (4362_CR55) 2002; 66 S Jenkins (4362_CR47) 1994; 21 V Arora (4362_CR36) 2014; 8 K Hojo (4362_CR53) 2009; 88 SS Socransky (4362_CR17) 1998; 25 NW Chilton (4362_CR25) 1960; 39 J Milleman (4362_CR7) 2022; 96 S Turesky (4362_CR28) 1970; 41 MWB Araujo (4362_CR4) 2015; 146 ID Mandel (4362_CR48) 1988; 15 PJ McMurdie (4362_CR31) 2013; 8 FE Dewhirst (4362_CR35) 2010; 192 MJ Anderson (4362_CR33) 2001; 26 DH Fine (4362_CR43) 1985; 12 DH Fine (4362_CR10) 2000; 27 JB Fine (4362_CR14) 1994; 65 DH Fine (4362_CR11) 2005; 32 RR Lobene (4362_CR23) 1986; 8 PE Kolenbrander (4362_CR51) 1993; 175 SS Socransky (4362_CR16) 2004; 19 CA Saxton (4362_CR26) 1989; 24 4362_CR29 GE Minah (4362_CR15) 1989; 16 E Marchetti (4362_CR49) 2011; 12 JA Aas (4362_CR18) 2005; 43 JP Ouhayoun (4362_CR46) 2003; 30 4362_CR21 N Wake (4362_CR41) 2016; 2 J Ainamo (4362_CR24) 1975; 25 ML Bosma (4362_CR22) 2024; 24 D Kubert (4362_CR44) 1993; 6 NC Sharma (4362_CR38) 2002; 15 JB Oksanen (4362_CR30) 2020; 2 National Dental Association - Minutes of the Executive Council (4362_CR2) 1909 PE Kolenbrander (4362_CR54) 2010; 8 ML Bosma (4362_CR6) 2022; 96 C Lozupone (4362_CR32) 2011; 5 P Pan (4362_CR45) 2000; 27 MC Lynch (4362_CR8) 2018; 18 E Zaura (4362_CR20) 2009; 9 I Tomas (4362_CR50) 2010; 38 EW Sayers (4362_CR34) 2021; 49 N Sharma (4362_CR5) 2004; 135 DH Fine (4362_CR12) 2007; 34 M Carda-Dieguez (4362_CR19) 2020; 12 S Zimmer (4362_CR39) 2006; 77 K Bauroth (4362_CR42) 2003; 134 HS Luis (4362_CR37) 2018; 16 |
| References_xml | – volume: 38 start-page: 541 issue: 7 year: 2010 ident: 4362_CR50 publication-title: J Dent doi: 10.1016/j.jdent.2010.03.012 – volume: 134 start-page: 359 issue: 3 year: 2003 ident: 4362_CR42 publication-title: J Am Dent Assoc doi: 10.14219/jada.archive.2003.0167 – volume: 8 start-page: ZC01 issue: 10 year: 2014 ident: 4362_CR36 publication-title: J Clin Diagn Res – volume: 9 start-page: 259 year: 2009 ident: 4362_CR20 publication-title: BMC Microbiol doi: 10.1186/1471-2180-9-259 – volume: 41 start-page: 41 issue: 1 year: 1970 ident: 4362_CR28 publication-title: J Periodontol doi: 10.1902/jop.1970.41.1.41 – volume: 88 start-page: 982 issue: 11 year: 2009 ident: 4362_CR53 publication-title: J Dent Res doi: 10.1177/0022034509346811 – volume: 6 start-page: 277 issue: 6 year: 1993 ident: 4362_CR44 publication-title: Am J Dent – volume: 24 start-page: 75 issue: 1 year: 1989 ident: 4362_CR26 publication-title: J Periodontal Res doi: 10.1111/j.1600-0765.1989.tb00860.x – start-page: 17 volume-title: Transactions of the National Dental Association year: 1909 ident: 4362_CR2 – volume: 135 start-page: 496 issue: 4 year: 2004 ident: 4362_CR5 publication-title: J Am Dent Assoc doi: 10.14219/jada.archive.2004.0217 – volume: 96 start-page: 8 issue: 3 year: 2022 ident: 4362_CR6 publication-title: J Dent Hyg – volume: 21 start-page: 397 issue: 6 year: 1994 ident: 4362_CR47 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.1994.tb00736.x – volume: 2 start-page: 16018 year: 2016 ident: 4362_CR41 publication-title: NPJ Biofilms Microbiomes doi: 10.1038/npjbiofilms.2016.18 – volume: 15 start-page: 351 issue: 6 year: 2002 ident: 4362_CR38 publication-title: Am J Dent – volume: 39 start-page: 344 year: 1960 ident: 4362_CR25 publication-title: J Dent Res doi: 10.1177/00220345600390021601 – volume: 43 start-page: 5721 issue: 11 year: 2005 ident: 4362_CR18 publication-title: J Clin Microbiol doi: 10.1128/JCM.43.11.5721-5732.2005 – volume: 96 start-page: 21 issue: 3 year: 2022 ident: 4362_CR7 publication-title: J Dent Hyg – volume: 77 start-page: 1380 issue: 8 year: 2006 ident: 4362_CR39 publication-title: J Periodontol doi: 10.1902/jop.2006.050362 – volume: 18 start-page: 6 issue: 1 year: 2018 ident: 4362_CR8 publication-title: BMC Oral Health doi: 10.1186/s12903-017-0454-6 – volume: 65 start-page: 30 issue: 1 year: 1994 ident: 4362_CR14 publication-title: J Periodontol doi: 10.1902/jop.1994.65.1.30 – volume: 66 start-page: 486 issue: 3 year: 2002 ident: 4362_CR55 publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.66.3.486-505.2002 – volume: 8 start-page: e61217 issue: 4 year: 2013 ident: 4362_CR31 publication-title: PLoS ONE doi: 10.1371/journal.pone.0061217 – volume: 431 start-page: 2957 issue: 16 year: 2019 ident: 4362_CR1 publication-title: J Mol Biol doi: 10.1016/j.jmb.2019.05.016 – volume: 27 start-page: 157 issue: 3 year: 2000 ident: 4362_CR10 publication-title: J Clin Periodontol doi: 10.1034/j.1600-051x.2000.027003157.x – volume: 8 start-page: 3 issue: 1 year: 1986 ident: 4362_CR23 publication-title: Clin Prev Dent – volume: 49 start-page: D92 issue: D1 year: 2021 ident: 4362_CR34 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa1023 – volume: 42 start-page: 627 year: 1988 ident: 4362_CR40 publication-title: Annu Rev Microbiol doi: 10.1146/annurev.mi.42.100188.003211 – volume: 146 start-page: 610 issue: 8 year: 2015 ident: 4362_CR4 publication-title: J Am Dent Assoc doi: 10.1016/j.adaj.2015.02.011 – volume: 2 start-page: 5 year: 2020 ident: 4362_CR30 publication-title: In – volume: 12 start-page: 660 issue: 8 year: 1985 ident: 4362_CR43 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.1985.tb00937.x – volume: 34 start-page: 652 issue: 8 year: 2007 ident: 4362_CR12 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.2007.01096.x – volume: 8 start-page: 471 issue: 7 year: 2010 ident: 4362_CR54 publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro2381 – volume: 19 start-page: 352 issue: 6 year: 2004 ident: 4362_CR16 publication-title: Oral Microbiol Immunol doi: 10.1111/j.1399-302x.2004.00168.x – volume: 78 start-page: 1935 issue: 10 year: 2007 ident: 4362_CR13 publication-title: J Periodontol doi: 10.1902/jop.2007.070120 – volume: 5 start-page: 169 issue: 2 year: 2011 ident: 4362_CR32 publication-title: ISME J doi: 10.1038/ismej.2010.133 – volume: 16 start-page: e73 issue: 2 year: 2018 ident: 4362_CR37 publication-title: Int J Dent Hyg doi: 10.1111/idh.12307 – volume: 12 start-page: 1687397 issue: 1 year: 2020 ident: 4362_CR19 publication-title: J Oral Microbiol doi: 10.1080/20002297.2019.1687397 – ident: 4362_CR21 doi: 10.1186/s12903-024-04365-9 – volume: 12 start-page: 262 year: 2011 ident: 4362_CR49 publication-title: Trials doi: 10.1186/1745-6215-12-262 – volume: 26 start-page: 149 issue: 3 year: 2013 ident: 4362_CR9 publication-title: Am J Dent – volume: 4 start-page: CD012018 issue: 4 year: 2019 ident: 4362_CR3 publication-title: Cochrane Database Syst Rev – volume: 192 start-page: 2965 issue: 12 year: 2010 ident: 4362_CR52 publication-title: J Bacteriol doi: 10.1128/JB.01631-09 – ident: 4362_CR29 – volume: 32 start-page: 335 issue: 4 year: 2005 ident: 4362_CR11 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051x.2005.00674.x – volume: 24 start-page: 178 issue: 1 year: 2024 ident: 4362_CR22 publication-title: BMC Oral Health doi: 10.1186/s12903-024-03924-4 – volume: 16 start-page: 347 issue: 6 year: 1989 ident: 4362_CR15 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.1989.tb00003.x – volume: 25 start-page: 134 issue: 2 year: 1998 ident: 4362_CR17 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.1998.tb02419.x – volume: 175 start-page: 3247 issue: 11 year: 1993 ident: 4362_CR51 publication-title: J Bacteriol doi: 10.1128/jb.175.11.3247-3252.1993 – volume: 192 start-page: 5002 issue: 19 year: 2010 ident: 4362_CR35 publication-title: J Bacteriol doi: 10.1128/JB.00542-10 – volume: 25 start-page: 229 issue: 4 year: 1975 ident: 4362_CR24 publication-title: Int Dent J – volume: 15 start-page: 488 issue: 8 year: 1988 ident: 4362_CR48 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.1988.tb01020.x – volume: 30 start-page: 10 issue: Suppl 5 year: 2003 ident: 4362_CR46 publication-title: J Clin Periodontol doi: 10.1034/j.1600-051X.30.s5.4.x – volume: 27 start-page: 256 issue: 4 year: 2000 ident: 4362_CR45 publication-title: J Clin Periodontol doi: 10.1034/j.1600-051x.2000.027004256.x – volume: 21 start-page: 589 issue: 9 year: 1994 ident: 4362_CR27 publication-title: J Clin Periodontol doi: 10.1111/j.1600-051X.1994.tb00748.x – volume: 26 start-page: 32 issue: 1 year: 2001 ident: 4362_CR33 publication-title: Austral Ecol |
| SSID | ssj0017844 |
| Score | 2.3579836 |
| Snippet | Background
Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data.... Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data. A novel... Background Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data.... BackgroundTranslational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative abundance data.... Abstract Background Translational microbiome research using next-generation DNA sequencing is challenging due to the semi-qualitative nature of relative... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | 575 |
| SubjectTerms | Adult Alcohol Analysis Anti-Infective Agents, Local - therapeutic use Bacteria Bacterial Load - drug effects Biofilms Care and treatment Cell number Chemotherapy Clinical trials Dental Devices, Home Care Dental floss Dental plaque Dental Plaque - microbiology Dentistry Disease prevention DNA sequencing Drug Combinations Enumeration Essential oils Female Gingiva Gingivitis Gingivitis - microbiology Gum disease Gum diseases Humans Hygiene Intervention Listerine Male Medicine Metagenomics Methods Microbiomes Microbiota Microbiota (Symbiotic organisms) Microbiota - drug effects Middle Aged Mouthrinse Mouthwashes Mouthwashes - therapeutic use Nucleotide sequencing Off odor Oral and Maxillofacial Surgery Oral diseases Oral hygiene Oral microbiome Physiological aspects Preventive dentistry Propidium monoazide Salicylates - therapeutic use Single-Blind Method Species richness Terpenes - pharmacology Terpenes - therapeutic use Toothbrushing Toothbrushing - methods Toothpaste Young Adult |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHoALgvIKLchISBxo1I3teL3cyqOqkEBColJvlu3YYtU2u9rdHPpL-neZcZylKUJcuG1ir2R7xp5v4plvAN6oKbE8ybqchFqXZDHKmbOTUgdurfSWWKwo2uKbOjmVX87qsxulvigmrKcH7hfuUIvohNUNbzTdwgnLfUW0UsJ6JyfS0emLZmxwpvL9wVRLOaTIaHW4pq8tdF9JQReUJ3Q1MkOJrf_PM_mGUbodMHnr1jQZo-OH8CCjSHbUj_4R3AntLtz7RJE_VLxtF-5-zXfmj-H6e2fblEqGBxuzmYSELSJD7MdyPAc9ulWXvkcdsHiBY06_bNuwS6qyh-OgN2zRsnW3XKXaRnPU0tRj3bnt8_LC4rTY5bxneNrY94yqmoRwzoYsTJZKhTyB0-PPPz6elLkcQ-nR7diUXmgrnVM1JxJFrmqH4uDoAgXFpY4NJ7YzFarYxJlF2CVVbbXyUYqoPS6_eAo77aINz4Fp0UxnCFS515VsPLeIMmVlaxmF09KFAt4N0jHLnnXDJG9FK9PL0qAsTZKluSrgAwlw25MYs9ML1COT9cj8S48KeEviN7SvUcbe5vQEHDAxZJkjPLhwhgiQC9gf9cT96MfNgwKZfB6sDTpmipChFAW83jbTPynGrQ2LjvogtFaUWVzAs17ftlMSaLQQ3OkC9EgTR3Met7Tzn4ktHI0Z4rRqUsDBoLS_x_X3RX3xPxZ1D-7ztOnqspruw85m1YWXCOI27lXar78AfGFB-g priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1tb9MwED6NIQFfEIy3wEBGQvCBZTS247pICI2XaUIaEhKV9s2yHQcquqRrG4n-Ev4ud27SkTH41sROZfvOuce5u-cAnqkhsTzJPB2EXKdkMdKRs4NUB26t9JZYrCja4rM6GstPJ_nJFnThtu0CLi492lE9qfF8uv_zbPUWN_ybuOG1erWgbynkjaSQCsoCWj2fnaVUWIocsG2VjStwFY0VJ8U_lueOhqGWssulufSvevYq0vr__fL-w3pdjKy84F6NVuvwFtxs4SY7WOvHbdgK1Q5c_0AhQlTlbQeuHbfO9Tvw60tjq5hzhm9AZlu2ElaXDEEiawM_6NLNm_jhao-VUxxz_GWrgp1SOT4cB91hdcUWzWweiyBNUJ1jj0XjNtezqcVpsdPJmgpqaV8zKn8Swg_WpWuyWFPkLowPP359f5S2dRtSj-eTZeqFttI5lXNiW-Qqdwh7OJ6VguJSlwUnWjQVsrIoRxbxmVS51cqXUpTa4_KLe7Bd1VV4AEyLYjhCRMu9zmThuUU4KjOby1I4LV1I4GUnHTNb03OYeKzRyqxlaVCWJsrSrBJ4RwLc9CRq7Xijnn8z7U41WpROWF3wQpPbV1juM-IxE9Y7OZAugRckfkMqiTL2ts1jwAETlZY5wDcczhCRdAK7vZ64cX2_uVMg0-m9wROcIggpRQJPN830JAXDVaFuqA9icEUpyAncX-vbZkoCrRuiQJ2A7mlib879lmryPdKKo9VDQJcNEtjrlPZ8XP9e1If_n8YjuMHjdsrTbLgL28t5Ex4jjlu6J3En_gbrskTf priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB5BkYALgvIKFGQkJA40YuPXermVhapCAgmJSr1ZtuOoK9rsandz6C_p3-2M86ApcOCWxI5kZ8aez5mZbwDe6imxPEmVT6IyOVmMfObdJDeROyeDIxYrirb4ro-O5dcTddLR5FAuzHX_fWH0hw39JyFPI4VLUIbPxW24o3DjpfC9uZ4PHoOpkbJPivnreyPDk_j5_9yFr5mhmyGSN_ykyfwcPoQHHW5kB62gH8GtWO_Cvc8U60Pl2nbh7rfOS_4YLn80rk7JY7iVMdfRjrBlxRDtsS6Cg279ukl_oPZZdYZjTleuLtk51dXDcdATtqzZplmtUzWjBepl6rFp_HC_OnM4LXa-aDmdtu4jozomMf5ifd4lS8VBnsDx4Zef86O8K8CQBzxobPMgjJPea8WJNpFr5RG_cDz0RM2lqUpO_GY6FlVZzRwCLamVMzpUUlQm4OcXT2GnXtbxOTAjyukMoSkPppBl4A5xpSyckpXwRvqYwfteOnbV8mzYdD4x2raytChLm2RpLzL4RAIcehJHdnqAqmO7JWeNqLxwpuSlIf-tcDwUREgmXPByIn0G70j8llYyyji4LiEBB0ycWPYAtyqcIULiDPZGPXEFhnFzr0C22wE2Fo9imrCgFBm8GZrpTYpqq-OyoT4IpjXlEmfwrNW3YUoCzRTCOZOBGWniaM7jlnpxmvjB0XwhMismGez3Svt7XP_-qC_-r_tLuM_T8lJ5Md2Dne26ia8QoG3967QyrwCC9jM3 priority: 102 providerName: Springer Nature |
| Title | Quantitative analysis of the effects of brushing, flossing, and mouthrinsing on supragingival and subgingival plaque microbiota: 12-week clinical trial |
| URI | https://link.springer.com/article/10.1186/s12903-024-04362-y https://www.ncbi.nlm.nih.gov/pubmed/38760758 https://www.proquest.com/docview/3066893743 https://www.proquest.com/docview/3056662694 https://pubmed.ncbi.nlm.nih.gov/PMC11102210 https://doaj.org/article/83fb3a8d2d804643a2c151793acb404b |
| Volume | 24 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: KQ8 dateStart: 20011201 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: GX1 dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central Free customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1472-6831 dateEnd: 20250131 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: M48 dateStart: 20011201 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1472-6831 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017844 issn: 1472-6831 databaseCode: C6C dateStart: 20011201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwELZgk4AXBONXYFRGQuKBRWtsx3V5QWvZNCFtgolJFS-W7ThQsSWlbR72l_Dvcuc4HRmCl6iOXcnOnX2f7bvvCHktR8jyJPJ06HOVosVIx9YMU-WZMcIZZLFCb4tTeXwuPs7yWTxwW0W3ym5NDAt1UTs8I98HaCvRtgr-fvEzxaxReLsaU2jcJtsZQBXU6tFss-HKRkqILlBGyf0VnrngrSW6XmC00FXPGAXO_r9X5j9M0023yRt3p8EkHT0g9yOWpAet8B-SW77aIXc_oP8PpnDbIXdO4s35I_Lrc2OqEFAGyxs1kYqE1iUFBEijVwcW7bIJp1J7tLyAPodfpiroJebag37gG1pXdNUsliHD0Rx0NbRYNXZTXlwYGBa9nLc8T2vzjmJuE-9_0C4Wk4aEIY_J-dHhl-lxGpMypA42H-vUcWWEtTJnSKXIZG4B0zDYCHnJhCoLhpxn0mdlUY4NgC8hc6OkKwUvlYPPz5-Qraqu_DNCFS9GY4CrzKlMFI4ZwJoiM7kouVXC-oS87aSjFy33hg57FiV1K0sNstRBlvoqIRMU4KYl8maHF_Xym47TUCteWm5UwQqFd7rcMJchSRk3zoqhsAl5g-LXOLtBxs7EIAXoMPJk6QNYvmCEAJMTsttrCbPS9as7BdJxVVjpax1OyKtNNf4TPd0qXzfYBgC2xPjihDxt9W0zJA6mCyCeSojqaWJvzP2aav49cIaDSQO0lg0Tstcp7XW__v1Rn_9_GC_IPRamU55mo12ytV42_iWAtLUdhJk4INuTw9NPZ1CayukgHHjA80QoeJ5Nvv4Gf14_Rg |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELaqIlEuCMpfoICRQBxo1MR2vF4khAql2tIfCamVejO248CKNll2N0L7JLwFz8iMk2xJEdx628Reyc6MZz7bM98Q8lwOkOVJZHHiMxWjx4iH1iSx8swY4QyyWGG0xZEcnYiPp9npCvnV5cJgWGVnE4OhziuHZ-RbAG0l-lbB306-x1g1Cm9XuxIajVrs-8UP2LLN3uztgHxfMLb74fj9KG6rCsQO0PM8dlwZYa3MGHIBMplZcMoMkLyXTKgiZ0jaJX1a5MXQAHoQMjNKukLwQrlhggegYPKvCZ4I5OofnC43eOlACdEl5ii5NcMzHrwlxVAPzE5a9JxfqBHwtyf4wxVeDtO8dFcbXODuLXKzxa50u1G222TFl-tkbQfjjbBk3Dq5ftje1N8hPz_VpgwJbGBOqWmpT2hVUECctI0iwUc7rcMp2CYtzmDM4Zcpc3qOtf1gHPiGViWd1ZNpqKg0hrUResxqu3yenBmYFj0fN7xSc_OaYi0V77_RLveThgIld8nJlYjrHlktq9I_IFTxfDAEeMycSkXumAFsK1KTiYJbJayPyKtOOnrScH3osEdSUjey1CBLHWSpFxF5hwJc9kSe7vCimn7R7bLXiheWG5WzXOEdMjfMpUiKxo2zIhE2Ii9R_BqtCcjYmTYpAgaMvFx6G8wlzBBgeUQ2ej3BCrh-c6dAurVCM32xZiLybNmM_8TIutJXNfYBQC8xnzki9xt9W06Jg6sESKkionqa2Jtzv6Ucfw0c5eBCAR2mSUQ2O6W9GNe_P-rD_0_jKVkbHR8e6IO9o_1H5AYLSyuL08EGWZ1Pa_8YAOLcPgmrkpLPV20GfgPJX3R9 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Rb9MwED7BJg1eEAwYgQFGQuKBRWtsx3V5K4xpFJhAMGlvlu04ULGlVds87Jfwd7lzkrIMeOAtiR3Jzt35Psd33wE8V0NieZJ5Ogi5TsljpCNnB6kO3FrpLbFYUbTFsTo6kZPT_PRSFn-Mdu-OJJucBmJpqlb786JsTFyr_SX9PaHzRwqioLyfi-uwqfORwu3X5ng8-TJZnyQMtZRdssxf3-w5pMjb_-fqfMk9XQ2dvHJ-Gt3S4W241eJJNm4U4A5cC9U23DigGCAq47YNWx_b0_O78PNzbauYVIZLHLMtHQmblQxRIGsjO-jWLer4Z2qPlWc45nhlq4KdU709HAc9YbOKLev5IlY5mqK-xh7L2q3v52cWp8XOpw3X08q-YlTfJIQfrMvHZLFoyD04OXz79c1R2hZmSD1uQFapF9pK51TOiU6Rq9whruG4GQqKS10WnHjPVMjKohxZBGBS5VYrX0pRao-fX9yHjWpWhQfAtCiGI4Ss3OtMFp5bxJsys7kshdPShQRedtIx84Z_w8R9i1amkaVBWZooS3ORwGsS4LoncWfHB7PFN9OaotGidMLqgheaznWF5T4jojJhvZMD6RJ4QeI3ZOEoY2_bRAUcMHFlmTEuYThDhMoJ7PZ6omX6fnOnQKZdGZYGt2iKMKIUCTxbN9ObFO1WhVlNfRBkK8oxTmCn0bf1lAS6L4R5OgHd08TenPst1fR75A1Ht4aILRsksNcp7e9x_fujPvy_7k9h69PBofnw7vj9I7jJo6XlaTbchY3Vog6PEcOt3JPWTH8BPNw_4g |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+analysis+of+the+effects+of+brushing%2C+flossing%2C+and+mouthrinsing+on+supragingival+and+subgingival+plaque+microbiota%3A+12-week+clinical+trial&rft.jtitle=BMC+oral+health&rft.au=Kyungrok+Min&rft.au=Bosma%2C+Mary+Lynn&rft.au=Gabriella%2C+John&rft.au=McGuire%2C+James+A&rft.date=2024-05-17&rft.pub=BioMed+Central&rft.eissn=1472-6831&rft.volume=24&rft.spage=1&rft_id=info:doi/10.1186%2Fs12903-024-04362-y |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6831&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6831&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6831&client=summon |